Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/3316
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kochubiei, Oksana | - |
dc.date.accessioned | 2013-05-20T06:52:13Z | - |
dc.date.available | 2013-05-20T06:52:13Z | - |
dc.date.issued | 2013-05-16 | - |
dc.identifier.citation | Kochubiei О. Hyperinterleukinemia, insulinresistance in hypertensive patients with prediabetes / О. Kochubiei // Внесок молодих вчених у розвиток медичної науки і практики: нові перспективи : матеріали науково-практичної конференції з міжнародною участю присвяченої Дню науки, Харків, 16 травня 2013 р. / ДУ Ін-т терапії ім. Л. Т. Малої НАМН України, Харк. нац. мед. ун-т [та ін.]. – Харків, 2013. – С. 28. | uk_UA |
dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/3316 | - |
dc.description | Interleukin-6 is pleiotropic cytokine with a key impact on immunoregulation and nonimmune events. Sudies have investigated the role of action/lack of action of Interleukin-6 in the pathogeneses obesity, insulin resistance, type 2 diabetes. Aim of the study: to evaluate interleukin-6 activity in hypertensive patients depend on prediabetes presence. Materials and methods: 73 hypertensive patients were examined. Common clinical investigations, were provided. Interleukin-6 plasma levels were detected using ELISA. Data is represented as Me (Q25-Q75). Median test were used, р <0,05. Results: Prediabetes was observed in 36,2% of hypertensive patients, in 71% insulinresistance in hypertensive patients with prediabetes vs 54 % insulinresistance in hypertensive patients were detected. Hypertensive patients with prediabetes (5,90 (5,20-7,10) %) characterized by significantly higher glycated haemoglobin levels as compared hypertensive patients (5,40 (4,70-6,97) %, р<0,05). Hypertensive patients were characterized by increased interleukin-6 activity (18,81 (13,14-26,69) pg/ml). In hypertensive patients with prediabetes decrease interleukin-6 activity (13,94 (11,00-16,94) pg/ml )were found. Conclusion: Hypertensive patients were characterized by increased interleukin-6 activity, in hypertensive patients with prediabetes decrease interleukin-6 activity were found, that can be explained by double effects of interleukin-6 family, representatives of which or can lead to insulinresistance development, or on the contrary can improve tissue insulinsensitivity. From other side, the possibility is not exclude that hypertension is a more strong incentive, which leads to hyperinterleukinemia in hypertensive patients. | uk_UA |
dc.description.abstract | Interleukin-6 is pleiotropic cytokine with a key impact on immunoregulation and nonimmune events. Sudies have investigated the role of action/lack of action of Interleukin-6 in the pathogeneses obesity, insulin resistance, type 2 diabetes. Aim of the study: to evaluate interleukin-6 activity in hypertensive patients depend on prediabetes presence. Materials and methods: 73 hypertensive patients were examined. Common clinical investigations, were provided. Interleukin-6 plasma levels were detected using ELISA. Data is represented as Me (Q25-Q75). Median test were used, р <0,05. Results: Prediabetes was observed in 36,2% of hypertensive patients, in 71% insulinresistance in hypertensive patients with prediabetes vs 54 % insulinresistance in hypertensive patients were detected. Hypertensive patients with prediabetes (5,90 (5,20-7,10) %) characterized by significantly higher glycated haemoglobin levels as compared hypertensive patients (5,40 (4,70-6,97) %, р<0,05). Hypertensive patients were characterized by increased interleukin-6 activity (18,81 (13,14-26,69) pg/ml). In hypertensive patients with prediabetes decrease interleukin-6 activity (13,94 (11,00-16,94) pg/ml )were found. Conclusion: Hypertensive patients were characterized by increased interleukin-6 activity, in hypertensive patients with prediabetes decrease interleukin-6 activity were found, that can be explained by double effects of interleukin-6 family, representatives of which or can lead to insulinresistance development, or on the contrary can improve tissue insulinsensitivity. From other side, the possibility is not exclude that hypertension is a more strong incentive, which leads to hyperinterleukinemia in hypertensive patients. | uk_UA |
dc.language.iso | en | uk_UA |
dc.subject | hyperinterleukinemia | uk_UA |
dc.title | Hyperinterleukinemia, insulinresistance in hypertensive patients with prediabetes | uk_UA |
dc.type | Thesis | uk_UA |
Appears in Collections: | Наукові роботи молодих вчених. Кафедра внутрішньої медицини № 1 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
КочубєйОА.doc | 25 kB | Microsoft Word | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.